RUNX2 stabilizes HIF-1α protein for regulating optimal angiogenesis in chondrocytes, but overexpressed RUNX2 in cases of cancer increases VEGF expression and anti-apoptotic activity under hypoxia, resulting in increased tumor progression. Here, RUNX2 is linked to cancer.